Methods In this open-label, single-center, casecontrol pilot study, patients with IIH (pwIIH) and a body mass index (BMI) of 30 kg/m 2 were offered to receive a GLP-1-RA (semaglutide, liraglutide) in addition to the usual care weight management (UCWM)
Accompanying symptoms may include: Nausea and vomiting that is persistent and does not respond to usual remedies Possible fever and elevated heart rate Abdominal tenderness when the area is touched Abdominal distension or bloating In severe cases, signs of systemic illness including confusion, shortness of breath, or low blood pressure Diagnosis of acute pancreatitis typically requires at least two of three criteria: characteristic abdominal pain, elevated pancreatic enzymes (lipase or amylase) greater than three times the upper limit of normal, and imaging findings consistent with pancreatic inflammation
Results from this trial will provide definitive head-to-head data on liver outcomes
The mucus layer on your intestines blocks absorption as well
The Bottom Line Wellbutrins weight-loss side effect is real, moderate, and usually safe